Sort
10,766 grants matching “checkpoint inhibitor”
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$361,468Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2024 · CA
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$361,442Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$361,441Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$361,440Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$361,357Ann Richmond · Vanderbilt University · R01 · FY2024 · CA
Study of Anti-Survival signals in NF1
$361,050Changyan Chen · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA
Regulation of PD-L1/PD-1 immune checkpoints by cis-interactions
$361,044Enfu Hui · University Of California, San Diego · R37 · FY2021 · CA
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$361,000Marco Colonna · Washington University · U01 · FY2011 · AI
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
$360,974Scott Hiebert · Vanderbilt University · R01 · FY2014 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$360,922Malay Haldar · University Of Pennsylvania · R37 · FY2023 · CA
Lynch Vaccine
$360,907Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$360,787Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$360,682Iman Osman · New York University School Of Medicine · R01 · FY2022 · CA
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION
$360,669Columbia University Health Sciences · R01 · FY2002 · GM
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$360,667Lanlan Shen · Baylor College Of Medicine · R01 · FY2025 · CA
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma
$360,653Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2024 · CA
Delineating how nucleic acid sensing in tumorcells regulate anti-tumor immune responses
$360,545Malay Haldar · University Of Pennsylvania · P01 · FY2024 · CA
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics
$360,522Loic Pierre Deleyrolle · University Of Florida · R01 · FY2024 · NS
Protein Kinase Signaling and Cell Cycle Control
$360,504Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2007 · ES
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
$360,406Rugang Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Antitumor-Antibiotics from Marine Microorganisms
$360,308William Fenical · University Of California, San Diego · R37 · FY2008 · CA
Antitumor-Antibiotics from Marine Microorganisms
$360,308William Fenical · University Of California, San Diego · R37 · FY2007 · CA
Regulatory Dendritic Cells in Cancer
$360,297Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA